Chronic Kidney Disease - CKD [abstract]
Journal of Ozone Therapy · 2018
DOI: 10.7203/jo3t.2.2.2018.11154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ozone Therapy, 2018. Verfasst von Vipul J. Kakkad.
Abstract (Originalsprache)
Total Number of CKD patients treated with OZONE THERAPY (rectal or IV saline): 40 (Most of them are under the treatment of Nephrologists) Two categories: - Serum Creatine 3 till 14 (Stage 4-5) No. of pts.17 1) Improvement observed for Stage 1-2-3 that is 1st category: On the basis of Clinical evaluation & Pathological criteria, 100% pts. improvement, with stable patho & physiological criteria, for more than 18 months 2) Improvement observed - for Stage 4-5 that is 2nd category: - On the basis of Clinical evaluation & Pathological criteria, 80% pts. Improved - Clinically & Pathologically. (Stable for > 3 months). - No improvement was observed in 20% of pts. 60% patients have shown Clinical & Pathological improvement & maintained for 6-12months. 80% patients have shown Clinical & Pathological improvement & maintained for 3-6 months. Clinical improvement as follows: - Anorexia decreased - Sense of well-being improved - Energy level increased - Edema decreased - No changes in weight except +/- 1kg. Pathological improvement: - Hb improved - Serum Creatinine & Serum BUN reduction - Proteinuria decreased. Ozone rectal insufflation are found to be more effective than IV ozone saline. Conclusion: Patients who received rectal ozone continuously for more then 10 procedures are better improved and could maintain the improvement.
Zitieren
APA
Kakkad, V. J. (2018). Chronic Kidney Disease - CKD [abstract]. Journal of Ozone Therapy. https://doi.org/10.7203/jo3t.2.2.2018.11154
Vancouver
Kakkad VJ. Chronic Kidney Disease - CKD [abstract]. Journal of Ozone Therapy. 2018. doi:10.7203/jo3t.2.2.2018.11154
BibTeX
@article{Kakkad2018,
author = {Kakkad, Vipul J.},
title = {Chronic Kidney Disease - CKD [abstract]},
journal = {Journal of Ozone Therapy},
year = {2018},
doi = {10.7203/jo3t.2.2.2018.11154}
}
EUVIMED